A Long-term Follow-up Study Evaluating Intravenous Injection of EXG001-307 in Patients With Type 1 SMA
ENROLLING_BY_INVITATION
Status
Conditions
Interventions
- OTHER: No intervention, only for observational studies
Sponsor
Guangzhou Jiayin Biotech Ltd